Immunotoxin that consists of humanized monoclonal anti-HER2 antibody TRASTUZUMAB covalently linked to anti-microtubule agent MAYTANSINOID DM1 for treatment of metastatic breast cancer in patients who previously received trastuzumab and a TAXANES, separately or in combination.
Synonyms: Trastuzumab Emtansine, Trastuzumab DM1, huN901 DM1, Trastuzumab-DM1, Ado-Trastuzumab Emtansine, Trastuzumab DM1 Conjugate, 0, Kadcyla, Ado Trastuzumab Emtansine, huN901DM1, huN901-DM1, Trastuzumab-DM1 Conjugate, SE2KH7T06F
Instance information
comment
2020 (2010) ,2020; ADO-TRASTUZUMAB EMTANSINE was indexed under TRASTUZUMAB and MAYTANSINE 2012-2019 and under ANTIBODIES, MONOCLONAL 2010-2011
identifier
D000080044